Pimco Corporate (PCN) 15.30 $PCN PIMCO Closed-End Funds

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pimco Corporate (PCN) 15.30 $PCN

PIMCO Closed-End Funds Declare Monthly Common Share Distributions
Marketwire Canada - Thu Sep 01, 3:45PM CDT
NEW YORK, NY--(Marketwired - Sep 1, 2016) - The Boards of Trustees/Directors of the PIMCO closed-end funds (each, a "Fund" and, collectively, the "Funds" have declared a monthly distribution for each Fund's common shares as summarized below. The distributions are payable on October 3, 2016 to shareholders of record on September 12, 2016, with an ex-dividend date of September 8, 2016.
PDI: 28.38 (-0.03), PCI: 20.21 (-0.03), PTY: 14.59 (-0.03), PCK: 10.72 (+0.07), PML: 13.60 (+0.05), PCM: 9.95 (-0.11), PCN: 15.30 (-0.16), RCS: 10.06 (-0.07), PCQ: 16.95 (-0.13), PMF: 16.71 (+0.16), PYN: 11.00 (+0.02), PFN: 9.45 (-0.02), PZC: 12.80 (-0.02), PGP: 20.50 (-0.06), PNI: 13.28 (+0.06), PNF: 13.21 (+0.03), PKO: 23.16 (-0.16), PMX: 12.69 (+0.06), PHK: 9.85 (-0.08), PFL: 10.53 (-0.04)

PIMCO Closed-End Funds Declare Special Year-End Distributions
Marketwired - Fri Dec 11, 3:30PM CST
The Boards of Trustees/Directors of the PIMCO closed-end funds (each, a "Fund" and, collectively, the "Funds" have declared a special year-end distribution for each Fund's common shares as summarized below. The distributions are payable on December 29, 2015 to shareholders of record on December 21, 2015, with an ex-dividend date of December 17, 2015. In addition to the regular monthly dividend, this special year-end distribution is being paid to allow the Funds to meet their 2015 distribution requirements for federal excise tax purposes. The Funds' total distribution will be taxable to shareholders in 2015.
PFN: 9.45 (-0.02), PDI: 28.38 (-0.03), PCI: 20.21 (-0.03), PKO: 23.16 (-0.16), PTY: 14.59 (-0.03), PCN: 15.30 (-0.16), RCS: 10.06 (-0.07)

Downtrend Call Working As PIMCO Corporate Income Fund Stock Falls 12.9% (PCN)
Comtex SmarTrend(R) - Fri Nov 27, 2:06PM CST
SmarTrend identified a Downtrend for PIMCO Corporate Income Fund (NYSECN) on September 26th, 2014 at $15.99. In approximately 14 months, PIMCO Corporate Income Fund has returned 12.86% as of today's recent price of $13.93.
PCN: 15.30 (-0.16)

PIMCO High Income Fund and PIMCO Corporate & Income Strategy Fund Announce Final Results of Tender Offers for Auction Rate Preferred Shares
Marketwired - Fri Nov 20, 5:53PM CST
PIMCO High Income Fund (NYSE: PHK) and PIMCO Corporate & Income Strategy Fund (NYSE: PCN) (each, a "Fund" and, together, the "Funds" today announced the expiration and final results for their issuer tender offers (each, a "Tender Offer" and, together, the "Tender Offers" for up to 100% of each Fund's outstanding auction rate preferred shares ("ARPS" at a price equal to 83%, with respect to PHK, and 82.5%, with respect to PCN, of the ARPS' per share liquidation preference of $25,000 per share (or $20,750 per share for PHK and $20,625 per share for PCN) and any unpaid dividends accrued through the expiration date of the Tender Offers. The Funds' Tender Offers expired on November 20, 2015 at 5:00 p.m. New York City time. All ARPS that were validly tendered and not withdrawn during the offering period have been accepted for payment.
PCN: 15.30 (-0.16), PHK: 9.85 (-0.08)

PIMCO Corporate Income Fund Has Returned 16.5% Since SmarTrend Recommendation (PCN)
Comtex SmarTrend(R) - Fri Nov 20, 9:39AM CST
SmarTrend identified a Downtrend for PIMCO Corporate Income Fund (NYSECN) on September 26th, 2014 at $15.99. In approximately 14 months, PIMCO Corporate Income Fund has returned 16.55% as of today's recent price of $13.34.
PCN: 15.30 (-0.16)

PIMCO Corporate Income Fund Shares Down 13.9% Since SmarTrend's Sell Call (PCN)
Comtex SmarTrend(R) - Thu Oct 22, 10:30AM CDT
SmarTrend identified a Downtrend for PIMCO Corporate Income Fund (NYSECN) on September 26th, 2014 at $15.99. In approximately 13 months, PIMCO Corporate Income Fund has returned 13.92% as of today's recent price of $13.76.
PCN: 15.30 (-0.16)

PIMCO High Income Fund and PIMCO Corporate & Income Strategy Fund Announce Tender Offers for Auction Rate Preferred Shares
Marketwired - Fri Oct 16, 3:35PM CDT
PIMCO High Income Fund (NYSE: PHK) and PIMCO Corporate & Income Strategy Fund (NYSE: PCN) (each, a "Fund" and, together, the "Funds" today announced that each Fund will commence a voluntary tender offer on or about October 16, 2015 (each, a "Tender Offer" and, together, the "Tender Offers" for up to 100% of its outstanding auction rate preferred shares ("ARPS" at a price equal to 83%, with respect to PHK, and 82.5%, with respect to PCN, of the ARPS' per share liquidation preference of $25,000 per share (or $20,750 per share for PHK and $20,625 per share for PCN) and any unpaid dividends accrued through the expiration date of the Tender Offer.
DB: 11.85 (-0.90), PCN: 15.30 (-0.16), PHK: 9.85 (-0.08)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 2

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Insightful Findings on gMG Treatments by UCB at AANEM 2024

Updated Category News Views 127

UCB Highlights Innovations in Generalized Myasthenia Gravis Treatments at AANEM 2024 UCB, a prominent global biopharmaceutical company, is gearing up to present its latest findings in the management of generalized myasthenia gravis (gMG) at the upcoming American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) meeting. The event, which will also feature...

Continue Reading
Lysander Funds Shares New Distributions Estimates for ETFs

Updated Category News Views 131

Lysander Funds Shares New Distributions Estimates Lysander Funds Limited recently made an announcement about the anticipated cash distributions for December 2024 for their exchange-traded funds (ETFs). The focus is on three notable ETFs: Lysander-Slater Preferred Share ActivETF, Lysander-Canso Corporate Treasury ActivETF, and Lysander-Canso Floating Rate ActivETF. Each of...

Continue Reading
Empowering Girls: Pace Center's Initiatives for Growth

Updated Category News Views 350

Introduction to the Capital Campaign Pace Center for Girls Hillsborough is excited to announce its capital campaign aimed at expanding its capacity and enhancing the support provided to girls in the community. Through dedicated efforts such as education, counseling, and training, this campaign signifies a crucial step towards bettering the future for girls in Hillsborough...

Continue Reading
Bank of America Sees Growth in Loans, Deposits Amid Profit Rise

Updated Category News Views 284

Bank of America Reports Increased Earnings and Efficiency Bank of America Corp (NASDAQ: BAC) has announced strong financial results for the second quarter, showcasing impressive growth in loans, deposits, and overall profitability. The bank reported a net income of $7.1 billion, a slight increase from $6.9 billion the previous year, along with an earnings per share (EPS)...

Continue Reading
Investigating Manitex International: A Closer Look at MNTX

Updated Category News Views 72

Examining Fair Treatment for Manitex International Shareholders Ademi LLP has launched an investigation into Manitex International, Inc. (NASDAQ: MNTX) due to concerns about possible breaches of fiduciary duty related to its recent transaction with Tadano. This investigation raises important questions about whether shareholders are being treated fairly in the financial...

Continue Reading